Corcept Therapeutics Inc.
$111.81
$0.99 (+0.89%)
$110.49Day Range$113.60
Key Statistics
Market Cap
$11.98B
Shares Outstanding
108.1M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Apr 14, 2004
Round Lot
100
Locale
US
Trading Data
Day Open
$110.82
Day High
$113.60
Day Low
$110.49
Volume
668.6K
VWAP
$111.85
Prev Close
$110.82
Transactions
--
Acc. Volume
--
About Corcept Therapeutics Inc.
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.
PHARMACEUTICAL PREPARATIONSSIC 2834730 employees101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA, 94065650.688.8803IPO Apr 14, 2004US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001088856
- Composite FIGI
- BBG000BKJG33
- Share Class FIGI
- BBG001S8QGV1
- Ticker Root
- CORT
- SIC Code
- 2834
About Corcept Therapeutics Inc. (CORT) Stock
Corcept Therapeutics Inc. (CORT) closed the 2026-09-16 session at $111.81, up 0.89% versus the previous close (+0.99). The stock opened at $110.82 and traded between $110.49 and $113.60 during that session. Session trading volume was 669K shares. The volume-weighted average price (VWAP) is $111.85.
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.
Corcept Therapeutics Inc. has a market capitalization of $11.98 billion. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. CORT is listed on the XNAS exchange. The company employs approximately 730 people. Corcept Therapeutics Inc. is headquartered in REDWOOD CITY, CA. The recorded listing date is 2004-04-14.
On this page you can find market CORT stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.